Correspondence 0001640334-23-002271 from Lexaria Bioscience Corp. (LEXX, LEXXW) (CIK 0001348362) (LEXX)
Lexaria Bioscience Corp. (LEXX, LEXXW) (CIK 0001348362)
Date: Dec. 6, 2023 · CIK: 0001348362 · Accession: 0001640334-23-002271
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-275810
Letter
lxrp_corresp.htmDecember 6, 2023
VIA EDGAR AND FACSIMILE
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F. Street, N.E.
Washington, D.C. 20549
Attention: Cindy Polynice
Re: Lexaria Bioscience Corp. (the “Company”)
Registration Statement on Form S-1
File No. 333-275810
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:30 p.m., Eastern Time, on Friday, December 8, 2023, or as soon thereafter as practicable.
If you have any questions, please call Avital Perlman, Esq. at 212-930-9700.
Very truly yours,
LEXARIA BIOSCIENCE CORP.
Show Raw Text
CORRESP
1
filename1.htm
lxrp_corresp.htmDecember 6, 2023
VIA EDGAR AND FACSIMILE
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F. Street, N.E.
Washington, D.C. 20549
Attention: Cindy Polynice
Re: Lexaria Bioscience Corp. (the “Company”)
Registration Statement on Form S-1
File No. 333-275810
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:30 p.m., Eastern Time, on Friday, December 8, 2023, or as soon thereafter as practicable.
If you have any questions, please call Avital Perlman, Esq. at 212-930-9700.
Very truly yours,
LEXARIA BIOSCIENCE CORP.
By:
/s/ Christopher Bunka
Name:
Christopher Bunka
Title:
Chief Executive Officer